Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive

NCT01262040 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT01262040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01262040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Not applicable
Overall status
Completed
Start date
December 14, 2010
Completion date
October 29, 2018
Enrollment
154 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, esophageal carcinoma, fallopian tube cancer, gastrointestinal carcinoma, lung cancer, ovarian cancer, pancreatic carcinoma, peritoneal cancer